Autres langues Petros Pharmaceuticals

Actions

PTPI

US71678J3086

Marché Fermé - OTC Markets 21:57:17 14/08/2026			Varia. 5j.	Varia. 1 janv.
0,002700 ^USD	-20,59%		-15,62%	-66,04%

13/08	Petros Pharmaceuticals, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
18/06	Petros Pharmaceuticals, Inc. annonce des changements au sein de sa direction, effectifs au 18 juin 2026	CI

Autres langues

13/08	Petros Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
18/06	Petros Pharmaceuticals, Inc. Announces Executive Changes, Effective June 18, 2026
18/06	Petros Pharmaceuticals, Inc. Announces Principal Financial Officer Changes, Effective June 18, 2026
13/05	Petros Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
15/04	Petros Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
15/04	Petros Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt
13/11	Petros Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
14/08/25	Petros Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
27/05/25	Petros Pharmaceuticals, Inc.(OTCPK:PTPI) dropped from S&P TMI Index
22/05/25	Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets
21/05/25	Petros Pharmaceuticals, Inc.(OTCPK:PTPI) dropped from NASDAQ Composite Index
15/05/25	Petros Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
06/05/25	Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform
01/05/25	Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches
29/04/25	Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms
31/03/25	Petros Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
31/03/25	Petros Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt
28/03/25	Sekur Private Data Ltd. (OTCQB: SWISF) (CSE: SKUR): Cybersecurity Platform Redefines Privacy
27/03/25	"Cybersecurity, Healthcare Innovators PTPI, SWISF, OCEA, DGLY, LYT, SIGL, Amid FBI Warnings, Signal App Breach, and Data Privacy Crisis"
20/03/25	Petros Pharmaceuticals : to Partner with Renowned Big Data Provider to Enable Rx to OTC Switch Across Multiple Indications
20/03/25	Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications
19/02/25	Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants
18/02/25	Petros Pharmaceuticals Prices $9.6 Million Public Offering of Shares, Warrants
18/12/24	Petros Pharmaceuticals - Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market valued at over $38 Billion annually
17/12/24	Petros Pharmaceuticals, Inc. Announces Proprietary Technology Addressing the Rx-To-OTC Switch Self-Care Market Valued at over $38 Billion Annual